Landos Biopharma Inc (LABP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 0 | 0 | 18,000 | 0 | 0 |
| Gross Profit | N/A | N/A | 18,000 | N/A | N/A |
| Operating Expenses | 22,727 | 40,561 | 56,816 | 30,676 | 13,290 |
| Operating Income | -22,727 | -40,561 | -38,816 | -30,676 | -13,290 |
| Interest Expense | 0 | 0 | 0 | 0 | 304 |
| Other Income | 792 | 1,285 | 394 | 532 | 127 |
| Pre-tax Income | -21,935 | -39,276 | -38,422 | -30,144 | -13,467 |
| Net Income Continuous | -21,935 | -39,276 | -38,422 | -30,144 | -13,467 |
| Net Income | $-21,935 | $-39,276 | $-38,422 | $-30,144 | $-13,467 |
| EPS Basic Total Ops | -3.50 | -9.76 | -10.20 | -24.70 | -11.80 |
| EPS Basic Continuous Ops | -3.50 | -9.76 | -10.23 | -24.65 | -11.82 |
| EPS Diluted Total Ops | -3.50 | -9.76 | -10.20 | -24.70 | -11.80 |
| EPS Diluted Continuous Ops | -3.50 | -9.76 | -10.23 | -24.65 | -11.82 |
| EPS Diluted Before Non-Recurring Items | -3.50 | -9.80 | -10.20 | -24.70 | N/A |
| EBITDA(a) | $-22,683 | $-38,834 | $-37,446 | $-30,539 | $-13,187 |